Evaluation of prothrombin complex concentrate, recombinant activated factor VII and fibrinogen concentrate to reverse apixaban in a rabbit model

被引：0
|
作者：
Martin, A-C. [1 ]
Le Bonniec, B. [2 ]
Lecompte, T. [3 ]
Dizier, B. [2 ]
Emmerich, J. [2 ]
Fischer, A-M. [4 ]
Samama, C-M. [5 ]
Godier, A. [5 ]
机构：
[1] Mil Hosp HIA Val de Grace, Paris, France
[2] Paris Descartes Univ, Inserm U765, Paris, France
[3] Univ Hosp Nancy, Nancy, France
[4] Hop Europeen Georges Pompidou, AP HP, Paris, France
[5] Hosp Hotel Dieu, AP HP, Paris, France
来源：
CARDIOVASCULAR RESEARCH | 2012年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [21] Trends in the Use of Recombinant Activated Factor VII and Prothrombin Complex Concentrate in Heart Transplant Patients in Virginia
    Mazzeffi, Michael
    Beller, Jared
    Strobel, Raymond
    Norman, Anthony
    Wisniewski, Alexander
    Smith, Judy
    Fonner, Clifford E.
    McNeil, John
    Speir, Alan
    Singh, Ramesh
    Tang, Daniel
    Quader, Mohammed
    Yarboro, Leora
    Teman, Nicholas
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2024, 38 (03) : 660 - 666
  • [22] The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding
    Fries, Dietmar
    TRANSFUSION, 2013, 53 : 91S - 95S
  • [23] TREATMENT OF WARFARIN-RELATED INTRACRANIAL HEMORRHAGE: A COMPARISON OF PROTHROMBIN COMPLEX CONCENTRATE AND RECOMBINANT ACTIVATED FACTOR VII
    Pinner, Nathan A.
    Hurdle, April
    Oliphant, Carrie
    Reaves, Anne
    Lobo, Bob
    Sills, Allen
    CRITICAL CARE MEDICINE, 2008, 36 (12) : A176 - A176
  • [24] Treatment of Warfarin-Related Intracranial Hemorrhage: A Comparison of Prothrombin Complex Concentrate and Recombinant Activated Factor VII
    Pinner, Nathan A.
    Hurdle, April C.
    Oliphant, Carrie
    Reaves, Anne
    Lobo, Bob
    Sills, Allen
    WORLD NEUROSURGERY, 2010, 74 (06) : 631 - 635
  • [25] Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII
    Taketomi, Taro
    Szlam, Fania
    Levy, Jerrold H.
    Tanaka, Kenichi A.
    BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (01) : 106 - 108
  • [26] Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: A case series
    Schultz N.H.
    Lundblad R.
    Holme P.A.
    Journal of Medical Case Reports, 12 (1)
  • [27] Comparative study of prothrombin complex concentrate and the combination of Spinacia oleracea L. extract with prothrombin complex concentrate on the reversal of apixaban anticoagulation in a rabbit model
    Almarshad, Feras M.
    ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL, 2019, 8 (01): : 116 - 118
  • [28] The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
    Nina Haagenrud Schultz
    Hoa Thi Tuyet Tran
    Stine Bjørnsen
    Carola Elisabeth Henriksson
    Per Morten Sandset
    Pål Andre Holme
    Thrombosis Journal, 15
  • [29] The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
    Schultz, Nina Haagenrud
    Hoa Thi Tuyet Tran
    Bjornsen, Stine
    Henriksson, Carola Elisabeth
    Sandset, Per Morten
    Holme, Pal Andre
    THROMBOSIS JOURNAL, 2017, 15
  • [30] Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy - a porcine model
    Fries, D.
    Haas, T.
    Klingler, A.
    Streif, W.
    Klima, G.
    Martini, J.
    Wagner-Berger, H.
    Innerhofer, P.
    BRITISH JOURNAL OF ANAESTHESIA, 2006, 97 (04) : 460 - 467
12345